tiprankstipranks
Atossa Therapeutics (ATOS)
NASDAQ:ATOS
US Market
ATOS
Atossa Therapeutics
RESEARCH TOOLSreports

Atossa Therapeutics (ATOS) Income Statement

2,567 Followers

Atossa Therapeutics Income Statement

Last quarter (Q4 2025), Atossa Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Atossa Therapeutics's net income was $-10.94M. See Atossa Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -16.00K$ -17.00K$ -23.00K$ -8.00K$ -23.00K
Operating Expenses
$ 37.14M$ 27.62M$ 31.38M$ 27.69M$ 20.52M
Depreciation and Amortization
$ 16.00K$ 17.00K$ 23.00K$ 8.00K$ 23.00K
EBITDA
$ -37.13M$ -27.60M$ -31.35M$ -27.68M$ -20.50M
Operating Income
$ -37.14M$ -27.62M$ -31.38M$ -27.69M$ -20.52M
Other Income/Expenses
$ 2.37M$ 2.12M$ 1.28M$ 731.00K$ -85.00K
Pretax Income
$ -34.77M$ -25.50M$ -30.09M$ -26.96M$ -20.61M
Net Income
$ -34.77M$ -25.50M$ -30.09M$ -26.96M$ -20.61M
Per Share Metrics
Basic EPS
$ -4.04$ -3.00$ -3.60$ -3.15$ -2.70
Diluted EPS
$ -4.04$ -3.00$ -3.60$ -3.15$ -2.70
Weighted Average Shares Outstanding
 8.61M 8.39M 8.41M 8.44M 7.80M
Weighted Average Shares Outstanding (Diluted)
 8.61M 8.39M 8.41M 8.44M 7.80M
Currency in USD

Atossa Therapeutics Earnings and Revenue History